Juvenile Absence Epilepsy in Children Younger Than 16 Years: Managing Persistent Seizures
This protocol addresses juvenile absence epilepsy specifically in the pediatric population — patients younger than 16 years — where seizure control is the central clinical priority.
Clinical Population
Children (younger than 16 years) with juvenile absence epilepsy represent a distinct population requiring age-appropriate treatment consideration. Eligibility for certain interventions varies by age within this group.
Treatment Approach
When seizures are not adequately controlled with antiepileptic drug therapy, the structured protocol outlines specific alternative interventional and dietary approaches. The full regimen specifies the criteria for each option, including age-based eligibility considerations that apply within this pediatric group.
Treatment Goal
Decreased frequency or elimination of seizures, with improvement in quality of life in appropriately selected patients.
References
- Children (younger than 16 years)
- For patients with seizures that are not controlled with these agents, alternative treatments include surgical resection of the seizure focus, ketogenic diets, vagus nerve stimulators, and implantable brain neurostimulators.
- The ketogenic diet, a high-fat, low-carbohydrate, and low-protein diet, induces ketone body formation.
- It is approved by the U.S. Food and Drug Administration for use in persons older than 12 years.
- Surgical resection of the seizure focus in appropriately selected patients often results in decreased frequency or elimination of seizures with improvement in quality of life.
View source ↗